Palisade Bio (PALI) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -523.35% |
| Dec 31, 2025 | -213.21% |
| Sep 30, 2025 | -55.22% |
| Jun 30, 2025 | -45.42% |
| Mar 31, 2025 | -24.52% |
| Dec 31, 2024 | -18.83% |
| Sep 30, 2024 | 11.62% |
| Jun 30, 2024 | 11.06% |
| Mar 31, 2024 | -24.70% |
| Dec 31, 2023 | -8.91% |
| Sep 30, 2023 | 19.42% |
| Jun 30, 2023 | 14.42% |
| Dec 31, 2022 | -12.75% |
| Sep 30, 2022 | 10.03% |
| Jun 30, 2022 | -21.65% |
| Mar 31, 2022 | -163.68% |
| Dec 31, 2021 | -93.82% |
| Sep 30, 2021 | -41.50% |
| Jun 30, 2021 | -33.36% |
| Mar 31, 2021 | 41.11% |
| Dec 31, 2020 | -10.82% |
| Sep 30, 2020 | -42.09% |
| Jun 30, 2020 | -82.23% |
| Mar 31, 2020 | -137.72% |
| Dec 31, 2019 | -113.11% |
| Sep 30, 2019 | -150.06% |
| Jun 30, 2019 | -236.04% |
| Mar 31, 2019 | -152.09% |
| Dec 31, 2018 | -143.30% |
| Sep 30, 2018 | -179.89% |
| Jun 30, 2018 | -223.77% |
| Mar 31, 2018 | -82.81% |
| Dec 31, 2017 | 25.15% |
| Sep 30, 2017 | 24.66% |
| Jun 30, 2017 | 41.65% |
| Mar 31, 2017 | 59.75% |
| Dec 31, 2016 | 60.65% |
| Dec 31, 2015 | -49.50% |
| Sep 30, 2015 | 73.42% |
| Jun 30, 2015 | 67.21% |